Indonesia seeks to preserve historic railway assets as part of global heritage
Gigawatts Are Announced. Megawatts Must Be Energized.
Noah Kangian Adds 100+ New Services to MSP Panel’s Indian SMM Panel Service List
Astra Security Named Best Autonomous Pentesting Tool of 2026
Gatekeeper Now Available to Buy in AWS Marketplace, Giving Compliance-Driven Organisations a Faster Route to Vendor Governance
Preclinical Efficacy and Safety Results Indicate AlloCAR T™ Development Candidate Controls Tumor Growth without Off-Tumor/Normal Tissue…
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (the “Company”)…
SciSparc will examine the possibility of a public listing for its pharmaceutical activity while retaining…
Isranalytica 2023, the Annual meeting of the Israel Analytical Chemical Society, provided Clearmind with the…
– Dr. De Backer to assume CEO role on April 3, 2023 – – Upon…
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for…
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
The brain–computer interface company advances the industry with plans for a minimally invasive, reversible implant….
First Immunosynthen ADC product candidate enters the clinic CAMBRIDGE, Mass., Jan. 25, 2023 (GLOBE NEWSWIRE)…
Final study results show Grace Breeding’s NFT, an alternative to reduce urea, was superior or…
Topline results expected in first half of 2023 Trial sites open in Australia and United…
REDWOOD CITY, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”),…
-Statistically Significant Results in Performance of the Upper Limb PUL 2.0 (p=0.02) Extended to 18…
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in…
AGOURA HILLS, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
Boca Raton, Florida, Jan. 25, 2023 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics…
Recruitment ongoing in Europe, Asia-Pacific, and the U.S. for study of rapidly progressive Parkinsonian Disorder…
~ PEDMARK is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of…
BOCA RATON, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ: FWBI)…